HEPTEST: A suitable method for monitoring heparin during pregnancy

Clinical and Laboratory Haematology

Volumn 21, Issue 3, 1999, Pages 193-200

  Campbell, P J ^a   Tirvengadum, M A ^a   Pickering, W ^a   Cohen, H ^a,b   Ryan, K E ^a  

^a CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

APTT; Heparin; HEPTEST; Pregnancy; Thromboprophylaxis

Indexed keywords

ANTIBODY; COMPLEMENT; HEPARIN;

ARTICLE; BLOOD SAMPLING; DRUG MONITORING; HEPARINIZATION; HUMAN; IMMUNOASSAY; PARTIAL THROMBOPLASTIN TIME; PREGNANCY COMPLICATION; PRIORITY JOURNAL; THROMBOSIS;

EID: 0032775398     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.1999.00208.x     Document Type: Article

References (20)

1. Baa L., Coombe-Tanzali S., Conrad J., Horellow M.H. & Samama M. (1987) Laboratory monitoring of a new low molecular weight heparin (Enoxaparin) with a new clotting test (HEPTEST). Haemostasis 17, 127-135.
2. Badaracco M.A. & Clessy M.P. (1974) Recurrence of venous thromboembolic disease and the use of oral contraceptives. British Medical Journal 1, 215-217.
3. Bara L., Mardiguian J. & Samama M. (1990) In vitro effect on HEPTEST of low molecular weight heparin fractions and preparations with various anti-IIa and anti-Xa activities. Thrombosis Research 57, 585-592.
4. Bergqvist D., Burmack U., Frisell J., Hallbook T., Lindblad B. & Risberg B. (1988) Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily. A prospective double-blind multicentre trial on postoperative thrombosis. British Journal of Surgery 73, 204-208.
5. Brancazio L.R., Roperti K., Stierer R. & Laifer S. (1995) Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy. American Journal of Obstetrics and Gynecology 173, 1240-1245.
6. Dahlman T., Hellgren M. & Blomback M. (1989) Thrombosis prophylaxis in pregnancy with the use of subcutaneous heparin adjusted by monitoring heparin concentration in plasma. American Journal of Obstetrics and Gynecology 161, 420-425.
7. De Swiet M., Dorrington-Ward P., Fidler J. et al. (1990) Prolonged heparin therapy in pregnancy causes bone demineralisation. British Journal of Obstetrics and Gynaecology 90, 1129-1134.
8. Denson K.W.E. & Bonner J. (1975) Measurement of heparin in patients receiving subcutaneous heparin therapy. British Journal of Haematology 30, 139-144.
9. Ginsberg J.S., Hirsh J., Turner D.C., Levine M.N. & Burrows R. (1989) Risks to the fetus of anticoagulant therapy during pregnancy. Thrombosis and Haemostasis 61, 197-203.
10. Havenberg J., Giese C., Krodler A. & Zimmerman R. (1989) Comparative study on a new one-stage clotting assay for heparin and its low molecular weight derivatives. Haemostasis 1, 13-20.
11. Hirsh J. (1991) Heparin. New England Journal of Medicine 324, 1565-1567.
12. Howell R., Fidley M. & Letsky E. (1983) The risk of antenatal subcutaneous heparin prophylaxis; a controlled trial. British Journal of Obstetrics and Gynaecology 90, 1124-1128.
13. Iturbe-Alessio I., del Carmen Fonesca M., Mutchinik O., Santos M.A., Zajarias A. & Salazar E. (1986) Risks of anticoagulant therapy in pregnant women with artificial heart valves. New England Journal of Medicine 315, 1390-1393.
14. Jeffries W.S. & Bochner F. (1991) Thromoembolism and its management in pregnancy. Medical Journal of Australia 155, 253-257.
15. Letsky E. (1985) Thromboembolism during pregnancy. In: Coagulation Problems During Pregnancy (Ed, Letsky E.). London: Churchill Livingstone, pp. 29-62.
16. Lindahl A.K., Abildgaard V., Larsen M.L. et al. (1991) Extrinsic pathway inhibitor released to the blood by heparin is a more powerful inhibitor than is recombinant TFPI. Thrombosis Research 62, 607-614.
17. Rasmussen C., Wadt J. & Jacobsen B. (1994) Thromboembolic prophylaxis with low molecular weight heparin during pregnancy. International Journal of Gynaecology and Obstetrics 47, 121-125.
18. Stirling Y., Woolf L., North W.R.S., Seghatchian M.J. & Meade T.W. (1984) Haemostasis in normal pregnancy. Thrombosis and Haemostasis 52, 176-182.
19. British Society for Haematology. (1993) Maternal and Neonatal Haemostasis Working Party of the Haemostatis and Thrombosis Task Force. Guidelines on the prevention, investigation and management of thrombosis associated with pregnancy. Journal of Clinical Pathology 46, 489-496.
20. Yin E.T. (1985) A new single stage measurement of heparin by anti-factor Xa. Seminars in Thrombosis and Haemostasis 11, 243-244.